These analyses demonstrate the identification of a bona fide malignant craniopharyngioma showing clear malignant histological transformation, preserved exon 3 CTNNB1 mutation and heterozygous loss of TP53 variant. Here, CTNNB1 is linked to craniopharyngioma.